Global Bio-Imaging Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.biz delivers in-depth insights on the global bio-imaging market in its upcoming report titled, “Global Bio-Imaging Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global bio-imaging market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global bio-imaging market report has been segmented on the basis of technology, application, and region.

Request Covid - 19 Impact

Bio-imaging technologies can observe subcellular structures, entire cells over tissues, as well as the entire multicellular organisms. These technologies require minimal intervention of medical practitioners, and are able to provide 3D structures of living organisms in a human body. Examples of bio-imaging instruments include X-ray, magnetic resonance imaging (MRI), ultrasound technology, and others. These technologies are mostly non-invasive, and safe and help clinicians to monitor effects of drugs during or after treatments

Major factors driving growth of the global bio-imaging market include rising number of hospitals and diagnostic centers, and increasing need for early diagnosis of diseases such as cancer. Increasing demand for women’s healthcare, rise of healthcare IT and bioinformatics industry are also expected to fuel growth of the market over the forecast period. In addition, results obtained from bio-imaging technologies can be shared across various countries, which helps to speed-up diagnosis and treatment of the disease, and advancement of technologies such as portable technology, pill camera, and others are important factors expected to drive growth of bio-imaging technologies.

However, high-cost associated with bio-imaging instruments is a major factor restraining growth of the global bio-imaging market. Furthermore, bio-imaging instruments are unable to distinguish between benign and aggressive tumors, is another factor expected to hamper growth of this market over the forecast period.

Moreover, adoption of biological imaging technologies in food, and agriculture industries for evaluation of quality and detecting defects in food items to provide good quality assurance, is expected to gain traction in the coming years.

The market in North America accounted for majority share in terms of revenue in the global bio-imaging market, owing to early adoption of bio-imaging technologies, and continuous R&D activities to develop technologically sound techniques. The market in Europe accounted for second-highest revenue share in the global bio-imaging market, owing to increasing number of hospitals and medical centers, and presence of large number of players in the region.

Global bio-imaging market segmentation:

Segmentation by technology:

• Medical technology
• Molecular technology

Segmentation by end-user:

• Hospitals
• Diagnostic centers

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• BioClinica, Inc.
• Bracco Imaging S.p.A
• FONAR Corporation
• Bayer HealthCare Pharmaceuticals
• Covidien Pharmaceuticals
• Digirad Corporation
• Esaote S.p.A
• Hitachi Medical Corporation
• Gamma Medica Inc.
• GE Healthcare